Foundation Medicine, Inc., a global, patient-focused precision medicine company , today announced that it has received approval from the U.S. Food and Drug Administration (FDA) for FoundationOne ® CDx ...

Findings from a study of Veracyte’s Prosigna genomic assay and GRAIL’s multi-cancer early detection test were presented at ...

(Nasdaq: VCYT), a leading cancer diagnostics company, today announced the U.S. commercial launch of the Prosigna® Breast Risk of Recurrence (ROR) test, a genomic test for patients diagnosed with early ...

A genomic test could help thousands of breast cancer patients avoid chemotherapy without compromising their outcomes, according to results from a large international phase III clinical trial presented ...

More information on these findings will be presented at the 2026 ASCO Annual Meeting on June 1. The data come from a new ...

But while Ozempic is arguably the most recognizable drug in its class, it isn’t the only medication approved for weight management. Others include Wegovy and Saxenda, while newer drugs like ...

Immune cells in the uterus shortly after mating. Panels A–F show CD45+ immune cells, and panels G–L show ELANE+ neutrophils at two time points: 0.5 days (D0.5) and 3.5 days (D3.5) after mating. (A, G) ...

After years of being a controversial way of treating symptoms of menopause, hormone therapy is making a comeback. That’s due to a wide range of factors, including a large body of data that shows how ...

Researchers at São Paulo State University (UNESP) in Brazil have demonstrated in rats that a synthetic version of oxytocin can prevent anxiety-related behaviors caused by social stress. The study was ...

For decades, doctors have been puzzled by why women develop Alzheimer’s disease at nearly twice the rate of men. Subscribe to read this story ad-free Get unlimited access to ad-free articles and ...